| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.4216 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.4216 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.5755 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.8299 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.8796 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.1299 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.2479 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.772 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 3.3735 | Relative Abundance | CON |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|